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ABSTRACT 
 
THE SYNTHESIS OF FLUORESCENT 3, 6-DIHYDROXYXANTHONES:  
   A ROUTE TO SUBSTITUTED FLUORESCEIN 
 
by 
 
Surajudeen Omolabake 
 
University of Wisconsin-Milwaukee, 2016 
Under the Supervision of Professor Alan W Schwabacher 
 
 
Xanthones belong to the family of compounds of the dibenzo-γ-pyrone framework. 
Naturally occurring xanthones have been reported to show a wide range of biological and 
medicinal activities including antifungal,19 antimalarial,20 antimicrobial,21 antiparasitic,22 
anticancer,23 and inhibition of HIV activity in cells.24 Xanthones have also been used as a 
turn on fluorescent probe for metal ions,32 including use as pH indicators, metal ion 
sensors, in molecular biology, medicinal chemistry and in the construction of other dyes. 
   Several methods have been developed for the synthesis of this important class of 
compounds. These methods have several limitations including commercially unavailable 
or very expensive starting materials, harsh reaction conditions, and multiple steps leading 
to low overall yields.  
In this report I present a simple and efficient method to make 3,6-
dihydroxyxanthones in high yields starting with cheap and commercially available starting 
materials. This transformation involves Friedel-Crafts acylation, Friedel-Crafts alkylation 
and cyclization of the resulting diarylmethyl cation in a manner mechanistically equivalent 
to the formation of fluorescein with trifluoroacetic anhydride playing the role of phthalic 
anhydride. 
 
 
                                                                   iii 
 
 
 
 Fluorination of fluorophores can greatly enhance their photo-stability and improve 
their spectroscopic properties. 2’, 7’-difluoro derivative of fluorescein has a lower pKa 
compared to un-substituted fluorescein thereby making it less pH sensitive.   Our method 
offers an easier and efficient 2 steps sequence to make fluorinated xanthones in high yield 
compared to a 6 step sequence reported in the literature.1  
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1. LITERATURE REVIEW 
 
1.1 Fluorophores 
 
A fluorophore is the component of a compound that is mainly responsible for the absorption and 
emission of light.2 After absorption of light at a specific wavelength, it re-emits at usually a longer 
wavelength. The wavelength of the emitted depends on the nature of the fluorophore and its 
chemical environment. Fluorophore usually contain either aromatic ring systems or several 
conjugated double bonds. Common fluorophore containing compounds are shown in figure 1 
below; 
 
 
  
Figure 1.1 Common fluorophore containing compounds 
Fluorophores have wide applications and are mostly used to stain tissues, cells, or materials in a 
variety of analytical methods. 
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1.2 The Concept of Fluorescence 
Fluorescence is the emission of light from singlet excited states in which the electron in the excited 
orbital has opposite spin orientation as the ground-state electron.3 Transitions to the ground state 
are allowed and the emission rates are very fast so that fluorescent lifetimes are typically in the 
nanosecond range. Measurement of the time-resolved emission involves advanced optics due of the short 
timescale of fluorescence, making it a sensitive process. Fluorescence data are presented as emission 
data which is a plot of fluorescence intensity against wave number. The Jablonski diagram is 
frequently used to illustrate the process that occurs when light is absorbed and re-emitted by a 
compound. 
  
Figure 1.2 The Jablonski diagram 
 
Light of specific wavelength interacts with an electron and causes its excitation to a higher-energy 
level S2, which then undergoes internal conversion according to Kasha’s rule to the first excited 
state S1. Several processes compete with fluorescence. The excited electron can either relax back 
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to the ground state which is fluorescence or can undergo intersystem crossing to the excited triplet 
state and then relax to the ground state a process termed phosphorescence. Phosphorescence is a 
much slower process since it is spin forbidden and a result the rate constants for triplet emission 
are several orders of magnitude smaller than those for fluorescence. Compounds containing heavy 
atoms such as iodine are frequently phosphorescent. The heavy atoms promote intersystem 
crossing and thus enhance phosphorescence effectively reducing the efficiency of fluorescence 
termed quantum yield.  
1.3 Fluorescein 
Fluorescein is a synthetic organic fluorophore that was first reported in 1871 by Von Bayer.4 It is 
a dark orange compound that is soluble in methanol and slightly soluble in water. It is a highly 
fluorescent compound that absorbs light at 494nm and re-emits at 517nm in water and can be 
excited with the readily available argon ion laser. Fluorescein has a very high quantum yield of 
0.92. A problem with fluorescein is that it can exist in cationic, neutral and in anionic forms making 
its fluorescent properties pH dependent.5 
 
Scheme 1.1 pH Dependence of Fluorescein Equilibria 
 
Fluorine atom in certain positions in the fluorescein core reduces the pKa of the compound and is 
presented later in this work. A great number of fluorescein derivatives are commercially available 
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while the properties can be modified to tune its fluorescent properties thereby widening its range 
of applications 
1.3.1 Applications of Fluorescein 
The excitation and emission wavelength of fluorescein can be tuned by making derivatives of 
fluorescein. Many of such derivatives have been made and are commercially available thereby 
increasing the scope of fluorescein use. Fluorine substituted fluoresceins is particularly useful as 
tags for biomolecules. Some fluorosensor uses are highlighted below:  
Metal Sensors: Metals play very important role in biological systems. An increase or decrease in 
their concentration can be detrimental hence the need to monitor their concentration. A derivative 
of fluorescein that can detect copper selectively in the presence of other divalent metal ions has 
been reported.6 The fluorescence of the sensor is quenched when copper is added with a detection 
limit of 0.5μM 
 
Figure 1.3 Fluorescein based copper ion sensor 
pH Sensor: In some applications, it is very important to monitor the pH as a slight increase or 
decrease could affect the function of the system, an example is the cell. This usually would require 
non- invasive sensors. A fluorescein based pH sensor that can detect pH between 7 and 10 was 
reported.7  
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Figure 1.4 Fluorescein based pH sensor 
Reactive Oxygen Species (ROS) Sensor: A fluorescein derivative incorporating a disulfide 
linkage that can detect reactive oxygen species has been developed.8 The sensor turns on when 
oxidized and turns off in the reduced form. 
 
Scheme 1.2 Fluorescein based ROS sensor 
Enzyme activity sensors: A group prepared a fluorescein based enzyme sensor that can detect 
alkaline phosphatase.9 The fluorescence of the sensor was caged because of self-quenching in a 
polymer structure. The enzyme breaks the phosphoramidite bonds which then releases the free 
fluorescein and the fluorescence of the free fluorescein is detected and used to quantify the enzyme. 
 
Figure 1.5 Caged fluorescein based sensor 
Polymerizable Fluorescein Derivatives: Detection of nanoparticles is frequently based on 
fluorescent labels knowing their location and permitting quantification of cellular loading. A 
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fluorescein based sensor that can detect nanoparticles was reported.10 In their structure, fluorescein 
was modified with styryl monomers and are converted into polymer particles. 
 
Figure 1.6 Fluorescein based nanoparticle sensor 
1.3.2 Synthesis of Fluorescein 
Fluorescein was first prepared in the lab from the condensation of two molecules of 
resorcinol and one molecule of phthalic anhydride using zinc chloride as a catalyst.4 
Methanesulfonic acid is a more suitable Lewis acid and solvent for the formation of the product 
with improved yields.11 
 
Scheme 1.3 Synthesis of Fluorescein 
The mechanism of fluorescein synthesis involves the double Friedel-Craft’s acylation of resorcinol 
using phthalic anhydride. The key step of ether bridge formation depends on conjugation. 
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Scheme 1.4 Mechanism of Fluorescein formation 
 
A second method to make fluorescein is the xanthone route. Several methods to convert 3,6-
dihydroxyxanthones to derivatives of fluorescein have been reviewed in the literature.12 The 
general method is firstly protect the oxygen of the hydroxyl groups in the 3,6-dihydroxyxanthone 
and add a Grignard’s reagent after which an acid is applied as a dehydrating agent. In the scheme 
below a base lithium hydroxide is used to hydrolyze the ester to the free acid.48 
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Scheme 1.5 Formation of fluorescein derivative from 3,6-dihydroxyxanthone48 
A third method to synthesize fluorescein derivatives is the condensation of aryl aldehydes and 
resorcinol using methanesulfonic acid leading to a triarylmethane intermediate which is the 
oxidized to the fluorescein derivative13. 
     
Scheme 1.6 Synthesis of fluorescein derivative using aldehyde 
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The conditions used here is mild and metal sensitive analogues of fluorescein can be prepared 
this way. 
1.3.3 Effect of Fluorine on fluorescein 
When fluorescein based dyes are used in assays especially as fluorescein conjugates there occur 
the problem of photobleaching14 which is the loss of the fluorescent signal due to an irreversible 
photochemical reaction. The replacement of the hydrogen atoms in an organic molecule by 
fluorine results in a change in properties15 due to the high electronegativity and small atomic radius 
of the atom. When the hydrogens in fluorescein was substituted with fluorine it resulted in 
reduction in the pKa values compared to the unsubstituted fluorescein. The lower pKa values 
increased to increased resistance to photo-bleaching and diminished quenching when the dye is 
conjugated to proteins. 
 
Compound Abs/Em (nm) Quantum Yield pKa 
1 490/514 0.92 6.5 
2 480/514 0.97 4.8 
3 508/527 0.85 6.1 
4 508/527 0.96 4.5 
5 535/553 0.47 3.3 
Table 1.1 Physiochemical properties of fluorinated fluoresceins 
10 
 
 
1.4 Xanthones 
Xanthones are fluorescent organic compounds that are naturally occurring and whose general 
structure is depicted below. Over 1000 different types of xanthones have been reported in the 
literature.161718 The xanthone nucleus have been reported to show a wide range of biological and 
medicinal activities e.g. antifungal,19 antimalarial,20 antimicrobial,21 antiparasitic,22 anticancer,23 
and is able to inhibit HIV activity in cells.24 Xanthones have also been used as a turn on fluorescent 
probe for metal ions.32 The xanthone structure has also been described as a ‘privileged structure’ 
because the activity exhibited depends on the type and position of the substituents on the xanthone 
core.25 
 
Figure 1.7 The structure of Xanthone core and numbering 
Some examples of naturally occurring xanthones is shown below; these natural xanthones have 
been screened for drug activity. 
11 
 
  
Figure 1.8 Structure of some naturally occurring xanthones 
 
1.4.1 Classification of Xanthones 
Xanthones isolated from natural products can be classified into six main groups with other 
subclasses. The classes includes simple xanthones which includes both oxygenated and non-
oxygenated xanthones, xanthone glycosides, prenylated xanthones, xanthonolignoids, 
bisxanthones, and miscellaneous xanthones. Simple oxygenated xanthones is further divided into 
monooygenated xanthones, dioxygenated, trioxygenated xanthones, tetraoxygenated xanthones, 
pentaoxygenated xanthones and hexaoxygenated xanthones.26 
Xanthone Glycosides 
This group of xanthones have a glucose molecule attached to the core of the xanthone backbone 
and can be divided into 2 groups which includes C-glycosides and O-glycosides.  In C-glycosides, 
C–C bond links the sugar moiety to the xanthone core and they are resistant to acidic and enzymatic 
breakdown due to the C-C bond strength while the O-glycosides have typical glycosidic bond 
linkage which are prone to hydrolysis. 2,-C-β-D-glucopyranosyl-1,3,6,7-tetrahydroxyxanthone is 
12 
 
abundant in and was first isolated from Mangifera indica.27 The common O-glycoside 3,7,8-
trihydroxyxanthone-1-O-β-laminaribioside is gotten from the fern species.28 
 
Figure 1.9 Structure of C-glycoside and O-glycoside  
Prenylated Xanthones 
Prenylated xanthones contains either a benzofuran or benzopyran ring fused to the xanthone core 
and are present in many natural products. These compounds also are bioactive. About 273 
prenylated xanthones are known. caloxanthone O and caloxanthone P are two new prenylated 
xanthones that have been isolated from Calophyllum inophyllum.29 Caloxanthone O was also 
reported to be cytotoxic activity against the human SGC-7901 cell line with the IC50 value of 22.4 
μg mL-1, caloxanthone P showed no activity on screening with the human gastric cancer cell line 
SGC-7901.29 
 
Figure 1.10 Structures of Caloxanthone O and Caloxanthone P 
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Xanthonolignoids 
This numbers of xanthones in this class is small in numbers. The first xanthonolignoid isolated is 
from Kielmeyera species. The xanthonolignoid Kielcorin was isolated from Kielmeyera 
variabilis.30 
 
Figure 1.11 Structure of Kielcorin 
Bisxanthones 
Twelve bisxanthones have been reportedly extracted from some higher plants, lichen and fungi. 
Examples include dicerandrols A, B and C were isolated from Phomopsis longicolla.31 
 
Figure 1.12 Structure of a bisxanthone 
Other xanthones have been isolated that do not fall into any of the classes discussed and are 
generally classified as miscellaneous xanthones. 
14 
 
1.4.2 Selected Applications of Xanthones 
The xanthone core have been reported to show a wide range of biological and medicinal activities 
e.g. antifungal,19 antimalarial,20 antimicrobial,21 antiparasitic,22 anticancer,23 and the ability of 
xanthone containing compounds to inhibit HIV activity in cells have been investigated.24 
Xanthones have also been used as a turn on fluorescent probe for toxic anions and cations,32 and 
has been applied as an insecticide.  
1.4.2.1 Fluorescent Probe for Metal Ions 
1,3,6-trihydroxyxanthone has been shown to selectively bind  Pb2+ in the presence of other metal 
ions and in the process turning on the fluorescence of the compound.32 
The emission spectra of the probe discriminating against other metal ions in the presence of Pb2+ 
is shown below 
 
 
Figure 1.13 Discrimination of Pb2+ in the presence of other cations (100μM) by L (1 μM) 
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The proposed stoichiometry of L to Pb2+ was proposed to be 2:1 
1.4.2.2 Antifungal Activity 
Simple monooxygenated, deoxygenated and trioxygenated xanthones were screened against yeast 
cells (C. albicans, C. glabata, C. neoformans) for their inhibitory effect.33 It was discovered that 
some of the xanthones tested exhibited strong inhibitory effects against those yeast cells with MIC 
values <10μg mL-1. Some of the xanthones that were inhibited the yeast cells includes 2-
hydroxyxanthone, 3-hydroxyxanthone, 3-hydroxyxanthone, 1,2-dihydroxyxanthone and 3,4-
dihydroxyxanthone. 
1.4.2.3 Antitumor Activity 
Several natural and synthetic xanthones containing hydroxyl and or prenyl groups have been 
investigated for their antitumor activity against human cell lines (HepG2, HCT-116, A549, 
BGC823, and MDA-MB-231.34 When the cancer cells were incubated for 48 hours with the 
xanthones, the compounds shown below with prenyl groups suppressed their growth with IC50 
values ≤ 10μM.34   
 
                             IC50 (μM) 
Compound HepG2 HCT-
116 
A549 BGC823 MDA-
MB-231 
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1.49 
 
18.5 
 
1.96 
 
6.72 
 
11.1 
 
 
9.81 
 
 
71.1 
 
20.6 
 
47.5 
 
44.4 
 
 
 
16.1 
 
 
8.35 
 
 
8.85 
 
 
73.4 
 
 
>100 
 
 
 
18.7 
 
 
6.15 
 
 
9.23 
 
 
10.0 
 
 
25.3 
Table 1.2 Antitumor activity of Xanthones 
 
1.4.3 Biosynthesis of Xanthones 
The amino acid phenylalanine derived from shikimate is the precursor in the biosynthesis of 
xanthones.35 The amino acid loses two carbon atoms from the side-chain and is oxidized to form m-
hydroxybenzoic acid. The m-hydroxybenzoic acid combines with three units of acetate to form the 
17 
 
shikimate-acetate intermediate, which then undergoes a ring closure to form the benzophenone 
that is further undergoes oxidative coupling catalyzed by enzymes to form the xanthone core. The 
benzophenone can undergo condensation to form the xanthone in two ways, it is either the attack 
is ortho or para to the hydroxyl group in ring B hence forming two different products. The 
mechanism for the pathway has been elucidated by experiments using plants fed with labelled 14C 
phenylalanine and 14C labelled acetate.36 The final step is an oxidative coupling reaction which 
has also been applied to synthesize xanthones.45 
 
Scheme 1.7 Biosynthesis of Xanthones from Phenylalanine 
 
1.4.4 Synthesis of Xanthones 
Naturally occurring xanthones are not readily available for drug studies due to the fact that the 
sources are limited, isolation and purification complexities, and substituent positions in the 
18 
 
xanthone core. Hence there is the dire need to synthesize these xanthones to provide a huge library 
of multi-substituted xanthones for structure activity relationship studies and other uses. Several 
methods to prepare this important class of compounds is presented in this report. 
1.4.4.1 Friedel-Crafts Acylation  
One of the earliest synthesis of xanthones is the POCl3 mediated acylation of resorcinol by 
derivatives of benzoic acid using ZnCl2 as a catalyst reported in 1955.37 The resulting 
benzophenone undergoes cyclization in water at high temperature and pressure. An example of 
this scheme is the reaction of 2,4-dihydroxybenzoic acid and resorcinol in the presence of POCl3 
and ZnCl2 to give 2,2’,4,4’-tetrahydroxybenzophenone and the condensation of the benzophenone 
to give 3,6-dihydroxyxanthone. 
 
Scheme 1.8 Condensation of Resorcinol and dihydroxybenzoic acid 
The yields using this procedure have been improved using P4O10 and Eaton’s reagent.38 
This procedure does not always give the desired products and sometimes demethylation may occur 
in benzophenones that has methoxy groups. A drawback however is that microwave assisted 
synthesis cannot be applied for large scale reactions. High temperature can be applied instead of 
acid: hydroxylated methylethylbenzoates and resorcinols undergo thermal condensation in 
refluxing diethylether to give the corresponding hydroxyxanthones.39 
19 
 
 
Scheme 1.9 Xanthones from condensation of benzoates and resorcinol in diphenylether 
Apart from the very harsh reaction conditions, the yield reported using this procedure is relatively 
poor. Microwaves have also been applied to cyclize the benzophenones to xanthones40 
 
 
Scheme 1.10 Microwave assisted synthesis of xanthones in water 
 
1.4.4.2 C1 Coupling Strategy 
Coupling of two substituted resorcinols to a C1 electrophile can lead to xanthones. The advantage 
of this strategy is seen where it is difficult to prepare both precursors for the Friedel-Craft’s 
approach.41  
Friedel-Crafts alkylation using bromodifluoro(phenylsulfanyl)methane 
Benzophenones were synthesized by the double Friedel-Craft’s acylation of various aromatics 
using bromodifluoro(phenylsulfanyl)methane and a lewis acid.42 A very stable α,α-
difluorocarbocation is generated by the reaction of the  bromodifluoro(phenylsulfanyl)methane 
and the lewis acid which is then used to the cyclization reaction.42 
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Scheme1.11 Double Friedel-Craft’s acylation using bromodifluoro(phenylsulfanyl)methane 
The substituted benzophenone acquired this way is then converted into the xanthone by the 
selective ortho-demethylation43 followed by condensation in water in a sealed tube. A major 
disadvantage of this procedure is that the starting material is either expensive or are not 
commercially available. 
The strategy adopted here is the use of difluoro(phenylsulfanyl)methane which is an excellent 
reagent for the generation of the α,α-difluorocarbocation which is a very stable carbocation by 
reacting with a lewis acid. Trapping the intermediate carbocation with an electron rich aromatic 
provided a succinct route for the formation of a C-C bond, and hydrolysis leads to benzophenone, 
convertible to xanthones. 
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Scheme 1.12 C-C formation using difluoro(phenylsulfanyl)methane 
A similar C1 coupling reaction leading to xanthone formation was done using a boron 
trifluoride–acetic acid complex.44 The Fluorine on the xanthone core could impart interesting 
properties on the compound that is why fluorinated compound is desirable14. 
 
Scheme 1.13 C1 Coupling Using boron trifluoride–acetic acid complex 
22 
 
 
1.4.4.3 Oxidative coupling of phenols 
The phenolic oxidative coupling reaction is an important reaction that has been extensively studied 
and has been reported to be an important step in the biosynthesis of naturally occurring 
compounds.45 This process is similar to the mechanism of the biosynthesis of xanthones earlier 
presented. Lewis and his coworkers first reported the oxidative coupling reaction of 2,3’,4-
trihydroxybenzophenone using alkaline ferricyanide to give 2,6-dihydroxyxanthone as the major 
product and 3,5-dihydroxyxanthone as a minor product.46 
 
Scheme 1.14 Oxidative coupling of 2,3’,4-trihydroxybenzophenone 
1.4.5 Fluorine Substitution 
Xanthones are particularly valuable as precursors to fluorescein derivatives. The synthesis of a 
fluorinated xanthone starts with the synthesis of fluorinated benzophenone derivative as reported 
by David S. Lawrence and co-workers.47 In the scheme shown below both fluorinated starting 
materials are expensive. Our method uses a relatively cheaper starting materials in less steps. 
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Scheme 1.15 8-steps fluorinated benzophenone synthesis 
The benzophenone was synthesized in an improved 5 step sequence was done by Blake R. 
Peterson and co-workers48staring with 2,4,5-trifluoronitrobenzene. 
 
Scheme 1.16 Improved 5 steps synthesis of benzophenone 
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The benzophenone was then heated in a sealed tube to 200oC forming the xanthone.49 
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2. RESULT AND DISCUSSION 
Given the utility of fluorescein and the great versatility their precursor xanthones, we set about to 
devise a better preparation of xanthones. As these substance can be fluorescent in their own right, 
we also decided to investigate the fluorescence of various substituents. 
We report here a simple and efficient procedure using readily available reagents to effect acylation 
of resorcinol molecules by a C1 equivalent leading to the formation of fluorescent xanthones. A 
key step in our procedure leading to the formation of 3,6-dihydroxyxanthones is the formation of 
a diarylmethyl cation as an intermediate. Trifluoroacetic acid behaves as the electrophile in this 
process and as the C1 equivalent.  Simply heating at reflux a solution of resorcinol in 1:1 
trifluoroacetic acid/methanesulfonic acid leads, after aqueous quench, to trifluoromethylcarbinols 
3.01-3.05.  
Our initial strategy to make these fluorescent xanthones is using triethyl orthoformate in a fashion 
similar to how fluorescein is made using phthalic anhydride. We had hoped that quenching the 
intermediate in water would lead to the alcohol after which it can then be oxidized to the ketone. 
 
Scheme 2.1 Initial strategy for xanthone formation 
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The initial reaction with resorcinol, triethyl orthoformate and with methanesulfonic acid and TFA 
in a 1:1 ratio did not give the product as expected. We got the trifluorocarbinol compounds 3.01 
contaminated with some unidentified material which exhibits yellow fluorescence under UV. The 
trifluorocarbinol 3.01 looked promising so we moved forward with it as we did not investigate the 
yellow fluorescent contaminant. It was discovered that triethyl orthoformate was not used to form 
the trifluorocarbinol compound so we excluded it from the scheme going forward. The scheme 
below shows the transformation. We knew it was not the dehydrated form because it was not 
fluorescent and as confirmed by MS, IR and further alkylation reactions. 
 
Scheme 2.2 Formation of trifluoromethylcarbinol 
 The transformation involves Friedel-Crafts acylation, Friedel-Crafts alkylation, and cyclization of 
the resulting diarylmethylcation in a manner mechanistically equivalent to the formation of 
fluorescein, with trifluoroacetic acid playing the role of phthalic anhydride.  The trifluorocarbinols 
compounds 3.01, 3.02, 3.03, 3.04 and 3.05 on initial screening has emission max of 571nm, 
620nm, 559nm, 554nm, and 590nm respectively. 
Entry X Y Yield (%) 
1 H H 80 
2 Cl H 98 
3 H CH3 72 
4 F H 77 
5 C6H13 H 94 
Table 2.1 Emission and yields of trifluoromethylcarbinols. 
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Using the same reflux conditions TFA/methanesulfonic acid, reflux) for n-hexylresorcinol did not 
give the desired product. Our interpretation based on the mass spectra of the compound is that the 
structure below was formed.  
 
A possible explanation is the high reactivity of the phenol due to the long chain electron donating 
alkyl group. The reaction was done at room temperature using the same acid ratio. The desired 
product was isolated with a very high yield. 
 
Table 2 shows that this procedure is effective with several substituents.  Interestingly, the 
trifluoromethylcarbinol compounds appear primarily in the carbinol form, rather as in the 
dehydrated form that is fluorescent, as shown by MS, IR and alkylation reactions.  
 
Scheme 2.3 Trimethylcarbinol and the dehydrated form 
The CF3 group favors sp3 over sp2 hybridization, encouraging formation of 
trifluoromethylcarbinol at the expense of the fluorescent dehydrated form.  The powerfully 
electron withdrawing CF3 group also lowers the pKa of these xanthines, facilitating deprotonation 
in neutral solution.  Despite the low content of dehydrated fluorescent form, these are intensely 
colored compounds with significant fluorescence.  Solutions of the trifluoromethylcarbinols 3.01-
3.05 constitute slow-release forms of highly fluorescent form 3.21-3.25, we speculate that these 
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compounds will be resistant to photobleaching since the major form is highly photostable.  
Fluorosensor molecules based on this chromophore may benefit from such stability. 
Also noteworthy is the fact that phenols containing substituent at the 5 position (5 methyl 
resorcinol and 1,3,5-trihydroxyphenol) did not give the desired product. A possible explanation is 
the hindrance that would result between the trifluoromethyl group and the substituent on the 5 
position. Friedel-Craft’s acylation is rarely efficient at a site with two ortho substituents. 
Conversion of substances trifluoroarylmethylcarbinols into xanthones requires removal of the CF3 
group. KOH in DMSO cleanly converts the carbinols to their corresponding xanthones, isolated 
by precipitation from acidic H2O.   
 
 
Scheme 2.4 Conversion of the trifluoromethylcarbinols to xanthones 
Entry X Y Yield (%) Emλmax (pH 7) 
1 H H 96 443nm 
2 Cl H 99 440nm 
3 H CH3 90 499nm 
4 F H 94 447nm 
5 C6H13 H 88 544nm 
Table 2.2 Emission and yields of xanthones 
In those cases where precipitation of the xanthones is not high yielding, extraction with 
ethylacetate gives product in very high yields. Because of the high stability of the xanthones, we 
have carried out the elimination at reflux in DMSO, allowing very short reaction times.  
However, even at 25˚C with 1M KOH, reaction was complete in approximately 1 h in most cases 
except in the 2,7-difluoro derivative where stirring overnight is required. 
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Fluorescein derivatives have been obtained by Grignard reagent addition to protected 
xanthones.12  Simply adding alkylating agent to the DMSO solution after CF3 cleavage leads in 
high yield to alkylated xanthones in a one-pot process from the trifluoromethylcarbinol 
compounds.  We also alkylated the already worked up xanthones using potassium hydroxide 
which also lead to high yields of products. Alkylating agents used is allyl bromide and benzyl 
bromide. Interestingly, this sequence is more facile than the reverse order: alkylation of the 
xanthone with allyl bromide and Cs2CO3 in DMSO cleanly forms the product, which on 
treatment with KOH in DMSO is completely stable to 110˚C, conditions that convert the 
phenolic form to ketone, suggesting the intermediate that expels CF3
- is a polyanion. 
 
Scheme 2.5 Alkylation of Xanthones and Trifluorocarbinols 
X Y R Yield i (%) Yield ii (%) 
H H CH2CHCH2 91  
Cl H CH2CHCH2 86  
F H CH2CHCH2 76  
F H C6H5CH2 98 91 
H H C6H5CH2  91 
C6H13 H C6H5CH2 92  
Table 2.3 Alkylation of the xanthones and yields 
The trifluoromethylcarbinol obtained when X and Y = H was also alkylated using benzyl 
bromide and allyl bromide in excellent yields. 
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Scheme 2.6 Alkylation of trifluorocarbinol compound 
We wanted to know whether the hydroxyl group of the phenol is necessary CF3 elimination to 
take place. Under the same reaction condition 3.16 was converted to 3.11 after stirring at room 
temperature for 7 hours compared to 60 minutes it took the free phenol to completely react. The 
free phenol makes the reaction goes faster compared to the protected phenol. 
 
Scheme 2.7 Conversion of protected trifluorocarbinol to ketone 
One advantage of this process is the ease with which 3,6-disubstituted 2,7-dihydroxyxanthones 
may be prepared from a single 4-substituted resorcinol.  Among related xanthine derivatives, the 
3,6-difluoro derivatives are highly prized, as the fluorines lower pKa values to a convenient 
range without quenching of fluorescence and also diminish photobleaching.  However, 4-
fluororesorcinol is relatively expensive, despite several recent improvements in its preparation.1  
We wondered whether the high reactivity of carbocation intermediates caused by CF3 
substitution would allow preparation of the desired fluorinated xanthones without use of the 4-
fluororesorcinol. 
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Scheme 2.8 Preparation of 2,7-difluoro-3,6-dihydroxyxanthone 
3,4-difluorophenol was treated with trifluoroacetic acid/methanesulfonic acid in the hope of 
preparing 2,3,6,7-tetrafluoroxanthone, which was expected to give 2,7-difluoro-3,6-
dihydroxyxanthone on treatment with KOH in DMSO by nucleophilic aromatic substitution of the 
fluoroxanthone  In the event, treatment of 3,4-difluorophenol, with trifluoroacetic 
acid/methanesulfonic acid under our standard conditions led in high yield to product with a yield 
of 77%, and upon KOH/DMSO treatment to the corresponding xanthone, the compound that 
would be formed from 4-fluororesorcinol!  This is noteworthy because the price of 3,4-
difluorophenol is ca. 4% that of 4-fluororesorcinol.  On treating 3-chloro-4-fluorophenol with a 
1:1 ratio of TFA and methanesulfonic acid, It was found that the rate of reaction was slow. After 
refluxing for 4 days and work up it was mostly starting material that was isolated even though 
NMR indicated the same product was formed. We speculate that the CF3-substituted carbocation 
intermediate is so reactive it undergoes nucleophilic aromatic substitution with trifluoroacetic acid 
as the nucleophile.  We believe such substitution precedes aqueous quench, since quenching into 
CH3OH instead of H2O leads to the diphenol, rather than the trimethyl ether.  However, we have 
no data to suggest whether substitution of F precedes the similar cyclization by hydroxy 
substitution.  
The spectrum that follows show the emission of the xanthines and xanthones followed by the 
absorbance of the xanthines and xanthones. 3.01, 3.02, 3.03, 3.04 and 3.05 and the xanthones 3.06, 
3.07, 3.08, 3.09 and 3.10 at pH 2, 7 and 9. Samples were prepared in 1cm path length quartz cells 
with absorbance less than 1.5 at the excitation and all emission wavelengths to uniformly 
illuminate across the sample, and to avoid the inner-filter effect. As seen from the spectrum the 
anionic forms of the xanthones displayed the highest fluorescence as determined by the number of 
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counts. The neutral forms were also fluorescent and the cationic forms were the least fluorescent 
forms. The spectrum is diaplayed this way for easy comparison of the emission and absorbance of 
the xanthines and xanthones and to see the effect of substitutuin. The concentration of xanthines 
and xanthones used for this study is 100μM and 10μM respectively. 
At pH 2, Compound 3.01 had A268nm = 4400M
-1cm-1 
               Compound 3.02 had A265nm = 3400M
-1cm-1 
      Compound 3.03 had A301nm = 8600M
-1cm-1 and another band at A519nm = 5200M
-1cm-1 
     Compound 3.04 had A280nm = 7700M
-1cm-1 
     Compound 3.05 had A276nm = 7300M
-1cm-1 
At pH 7, Compound 3.01 had A269nm = 5100M
-1cm-1 
               Compound 3.02 had A273nm = 3200M
-1cm-1 
      Compound 3.03 had A301nm = 8400M
-1cm-1  
     Compound 3.04 had A286nm = 7300M
-1cm-1, and A503nm = 1700M
-1cm-1 
     Compound 3.05 had A279nm = 7800M
-1cm-1 
At pH 9, Compound 3.01 had A279nm = 7800M
-1cm-1 
               Compound 3.02 had A281nm = 900M
-1cm-1, and A569nm = 780M
-1cm-1 
      Compound 3.03 had A280nm = 10200M
-1cm-1  
     Compound 3.04 had A301nm = 11300M
-1cm-1,  
     Compound 3.05 had A294nm = 8600M
-1cm-1 
A methyl group at the 4 and 5 position of the xanthine core generally leads to a much lower 
extinction coefficient. 
At pH 2, 3.06 had A322nm = 64000M
-1cm-1, At pH 7, 3.06 had A329nm = 50000M
-1cm-1 and at pH 9 
3.06 had A370nm = 84000M
-1cm-1 and A308nm = 20000M
-1cm-1 
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Figure 2.1 Emission spectra of xathines at pH 2 
 
 
Figure 2.2 Emission spectra of the Xanthines at pH 7 
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Figure 2.3 Emission spectra of the Xanthines at pH 7 
 
Figure 2.4 Emission spectra of the Xanthones at pH 2 
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Figure 2.5 Emission spectra of the Xanthones at pH 7 
 
Figure 2.6 Emission spectra of the Xanthones at pH 9 
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Figure 2.7 Absorbance spectra of the Xanthines at pH 2 (A= 3.01,B= 3.02,C= 3.03,D= 
3.04E= 3.05) 
 
 
Figure 2.8 Absorbance spectra of the Xanthines at pH 7 
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Figure 2.9 Absorbance spectra of the Xanthines at pH 9 
 
Figure 2.10 Absorbance spectra of the Xanthones at pH 2 
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Figure 2.11 Absorbance spectra of the Xanthones at pH 7 
 
Figure 2.12 Absorbance spectra of the Xanthones at pH 9 
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3. EXPERIMENTAL 
Unless otherwise noted, materials were obtained from commercial suppliers and used without 
purification. Tetrahydrofuran and diethyl ether were distilled from sodium and benzophenone. All 
experiments were performed under nitrogen atmosphere unlessotherwise noted. Organic extracts 
were dried over anhydrous magnesium sulfate. Nuclear magnetic resonance (NMR) experiments 
were performed with either a Bruker 300 MHz or Bruker 500 MHz instrument. All chemical shifts 
are reported relative to CDCl3 7.26 ppm for 1H. 1H and 13C NMR chemical shifts (δ) are reported 
in parts per million (ppm). Unless otherwise indicated, 1H and 13C NMR spectra were recorded 
in CDCl3 unless otherwise noted. Coupling constants (J) are reported in Hertz (Hz). Spectral 
splitting patterns are designated as follows: s, singlet; d, doublet; t, triplet; q, quartet; m, multiplet. 
Melting points were obtained using a Mel-temp II capillary apparatus and are uncorrected. MS 
was obtained using a Shimadzu LCMS 2020. 
 
 
9-(trifluoromethyl)-9H-xanthene-3,6,9-triol (3.01) 
A solution of resorcinol (2 g, 18.16 mmol, 1eq.) in mixed acids of methanesulfonic acid and 
trifluoroacetic acid (4 mL each) was refluxed in a 25mL round bottom flask while stirring and 
monitored by TLC (10% methanol in dichloromethane). Reaction went to completion after 2 hours. 
The reaction mixture was diluted into ice cold water (50 mL) after which product precipitated out 
and stirred for 2 hours. It was then filtered using a Buchner funnel and left to dry overnight under 
reduced pressure affording 2.74g. The crude product was purified from boiling water to give 2.2g 
of a needle-like crystals. M.p > 350oC. %. 1H NMR (300MHz, Methanol) δ 7.55 (d, J= 8.7, 2H), 
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6.60 (d,d, J= 2.1, 8.7, 2H), 6.49 (d, J= 2.1 2H); MS (ES) Calc. for C14H9F3O4 [M-1]
- 297.05; found 
297.05 
 
 
4,5-dimethyl-9-(trifluoromethyl)-9H-xanthene-3,6,9-triol (3.02) 
A solution of 2 methylresorcinol (442 mg, 3.56 mmol, 1eq.) in mixed acids of methanesulfonic 
acid and trifluoroacetic acid (2.5 mL each) was refluxed under nitrogen in a 25mL round bottom 
flask while stirring and monitored by TLC (10% methanol in dichloromethane). Reaction went to 
completion after 17 hours. The reaction mixture was diluted into ice cold water (50 mL) after 
which product precipitated out and was stirred for 30 mins. It was then filtered using a Buchner 
funnel and left to dry overnight under reduced pressure affording 420mg of the product 
corresponding to a yield of 72%. 1H NMR (300MHz, CDCl3) δ 7.54 (d, J= 8.7, 2H), 6.70 (d,d, J= 
8.7, 2H), 2.35 (s, 6H); MS (ES) Calc. for C16H13F3O4 [M-1]
- 325.08; found 325.10 
 
 
 
2,7-dihexyl-9-(trifluoromethyl)-9H-xanthene-3,6,9-triol (3.03) 
A solution of 4n-hexylresorcinol (71 mg, 0.36 mmol, 1eq.) in mixed acids of methanesulfonic acid 
and trifluoroacetic acid (1 mL each) was stirred under nitogen at room temperature in a 25mL 
round bottom flask and monitored by TLC (10% methanol in dichloromethane). Reaction went to 
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completion after 72 hours. The reaction mixture was then diluted into 15ml of ice cold water and. 
Product immediately precipitated which was stirred for 5 mins and filtered using a Buchner funnel 
with vacuum and dried overnight under pressure to afford 80mg of the desired compound. 
corresponding to a yield of 94%. No purification was attempted. 1H NMR (300MHz, CDCl3,) δ 
7.89 (s, 2H), 7.42 (s, 2H), 2.73 (m, 4H), 1.63 (m, 4H), 1.25 (m, 12H), 0.89 (m, 6H); MS (ES) Calc. 
for C26H33F3O4 [M-17]
+ 449.53; found 449.50  
 
 
 
 
2,7-dichloro-9-(trifluoromethyl)-9H-xanthene-3,6,9-triol (3.04) 
A solution of 4-chlororesorcinol (500mg, 3.5 mmol, 1eq.) in mixed acids of methanesulfonic acid 
and trifluoroacetic acid (2 mL each) was refluxed in a 25mL round bottom flask while stirring and 
monitored by TLC (10% methanol in dichloromethane). Reaction went to completion after 20 
hours. The reaction mixture was diluted into ice cold water (50 mL) after which product 
precipitated out and stirred for 30 mins. It was then filtered using a Buchner funnel and left to dry 
overnight under reduced pressure to give 0.62g of the product corresponding to a yield of 98%. 
The crude compound was crystallized from hot toluene. 1H NMR (300MHz, DMSO) δ 10.91 (s, 
2H), 7.61 (s, 2H), 7.57 (s, 1H), 6.80 (s, 2H); MS (ES) Calc. for C14H7Cl2F3O4 [M-1]
- 363.97; found 
364.00. 
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2,7-difluoro-9-(trifluoromethyl)-9H-xanthene-3,6,9-triol (3.05) 
A solution of 3,4-difluorophenol (500mg, 3.8 mmol, 1eq.) in mixed acids of methanesulfonic acid 
and trifluoroacetic acid (2 mL each) was refluxed under nitrogen in a 25mL round bottom flask 
while stirring and monitored by TLC (10% methanol in dichloromethane). Reaction went to 
completion after 68 hours. The reaction mixture was diluted into ice cold water (50 mL) after 
which product precipitated out and stirred for 2 hours. It was then filtered using a Buchner funnel 
and left to dry overnight under reduced pressure. The filtrate was then extracted with ethyl acetate 
to give a combined mass of 0.50g corresponding to a yield of 77%. The crude product was 
crystallized using boiling dichloromethane to give a red solid. 1H NMR (300MHz, CD3OD) δ 7.24 
(d, J= 11.1, 2H), 6.75 (d, J= 7.2, 2H); 19F NMR (300MHz, CD3OD) δ -81.70 (s, 3F), -143.79 (d,d 
J= 12, 1F); MS (ES) Calc. for C14H7F5O4 [M-17]
+ 317.03; found 317.00 
 
 
3,6-dihydroxy-9H-xanthen-9-one (3.06) 
A solution of 9-(trifluoromethyl)-9H-xanthene-3,6,9-triol (322mg, 1.08 mmol, 1eq.) in 
dimethylsulfoxide (5mL) and potassium hydroxide (0.30g, 5.4mmol, 5eq.) was refluxed under 
nitrogen in a 25mL round bottom flask while stirring and monitored by TLC (10% methanol in 
dichloromethane). Reaction went to completion after 32 minutes. Compound is indigo 
fluorescence under long range ultraviolet light. The reaction mixture was diluted into 5 parts by 
volume of ice cold water (25 mL) and product was precipitated using 2ml of 1M hydrochloric acid 
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solution and stirred for 10 minutes. It was then filtered using a Buchner funnel and left to dry 
overnight under reduced pressure. 0.24mg was obtained after drying corresponding to a yield of 
96%. The crude was purified using aqueous ethanol. M.p > 350oC (corresponds to what is reported 
in the literature). %. 1H NMR (300MHz, Methanol) δ 8.07 (d, J= 8.7, 2H), 6.86 (d, J= 8.7, 2H), 
6.82 (s, 2H); MS (ES) Calc. for C13H8O4 [M-1]
- 227.04; found 227.00 
 
 
2,7-difluoro-3,6-dihydroxy-9H-xanthen-9-one (3.07) 
A solution of 2,7-difluoro-9-(trifluoromethyl)-9H-xanthene-3,6,9-triol (204mg, 0.61 mmol, 1eq.) 
in dimethylsulfoxide (6mL) and potassium hydroxide (0.17g, 3.0mmol, 5eq.) was refluxed under 
nitrogen in a 25mL round bottom flask while stirring and monitored by TLC (10% methanol in 
dichloromethane). Reaction went to completion after 24 minutes. Compound fluorescence indigo 
under long range UV light. The reaction mixture was diluted into 10 parts by volume of ice cold 
water (56 mL) and product was precipitated using 2ml of 1M hydrochloric acid solution and stirred 
for 10 minutes. It was then filtered using a Buchner funnel and left to dry overnight under reduced 
pressure. The filtrate was then extracted with ethyl acetate to yield a combined mass of 150mg 
corresponding to a yield of 94%.Product is a light yellow solid which crystallized from aqueous 
ethanol. 1H NMR (300MHz, CD3OD) δ 7.80 (d, J= 10.5, 2H), 6.99 (d, J= 6.9, 2H); MS (ES) Calc. 
for C13H6F2O4 [M-1]
- 263.02; found 263.00 
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2,7-dichloro-3,6-dihydroxy-9H-xanthen-9-one (3.08) 
A solution of 2,7-dichloro-9-(trifluoromethyl)-9H-xanthene-3,6,9-triol (211mg, 0.57 mmol, 1eq.) 
in dimethylsulfoxide (5mL) and potassium hydroxide (0.16g, 2.85mmol, 5eq.) was refluxed under 
nitrogen in a 25mL round bottom flask while stirring and monitored by TLC (10% methanol in 
dichloromethane). Reaction went to completion after 25 minutes. Compound is indigo 
fluorescence under long range ultraviolet light. The reaction mixture was diluted into 5 parts by 
volume of ice cold water (25 mL) and product was precipitated using 2ml of 1M hydrochloric acid 
solution and stirred for 10 minutes. It was then filtered using a Buchner funnel and left to dry 
overnight under reduced pressure. 170mg was obtained after drying corresponding to a yield of 
99%. 1H NMR (300MHz, D2O) δ 7.84 (s, 2H), 6.45 (s, 2H); MS (ES) Calc. for C13H6Cl2O4 [M-1]- 
294.96; found 294.95 
 
 
 
3,6-dihydroxy-4,5-dimethyl-9H-xanthen-9-one (3.09) 
A solution of 4,5-dimethyl-9-(trifluoromethyl)-9H-xanthene-3,6,9-triol (213mg, 0.64 mmol, 1eq.) 
in dimethylsulfoxide (5mL) and potassium hydroxide (0.18g, 3.2mmol, 5eq.) was refluxed under 
nitrogen in a 25mL round bottom flask while stirring and monitored by TLC (10% methanol in 
dichloromethane). Reaction went to completion after 25 minutes. Compound is indigo 
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fluorescence under long range ultraviolet light. The reaction mixture was diluted into 5 parts by 
volume of ice cold water (26 mL) and product was precipitated using 2ml of 1M hydrochloric acid 
solution and stirred for 10 minutes. It was then filtered using a Buchner funnel and left to dry 
overnight under reduced pressure. 85mg was obtained after drying corresponding to a yield of 51% 
initial yield. The filtrate then was extracted with ethyl acetate to give a total yield of 90%. 1H NMR 
(300MHz, D2O) δ 7.76 (d, J= 9.0, 2H), 6.66 (d, J= 9.0, 2H), 2.24 (s, 6H); MS (ES) Calc. for 
C15H12O4 [M+1]
+ 257.07; found 257.25 
 
 
2,7-dihexyl-3,6-dihydroxy-9H-xanthen-9-one (3.10) 
A solution of 2,7-dihexyl-9-(trifluoromethyl)-9H-xanthene-3,6,9-triol from (80 mg, 0.17 mmol, 
1eq.) in dimethylsulfoxide (3 mL) in which potassium hydroxide (48mg, 0.85mmol, 5eq.) has been 
added was refluxed under nitrogen in a 25mL round bottom flask while stirring and monitored by 
TLC (10% methanol in dichloromethane). Reaction went to completion after 5 minutes. The 
reaction mixture was diluted into 25ml of ice cold water. Product immediately precipitated which 
was stirred for 5 mins and filtered using a Buchner funnel under vacuum and dried overnight under 
pressure to afford 60mg of the desired compound corresponding to a yield of 88%. 1H NMR 
(300MHz, CDCl3,) δ 7.98 (s, 2H), 6.80 (s, 2H), 2.99 (m, 4H), 2.67 (m, 4H), 2.60 (m, 4H), 1.25 (m, 
8H), 0.83 (m, 6H), 0.87 (m, 8H); MS (ES) Calc. for C39H44O4 [M-H]
- 395.52; found 395.35 
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3,6-bis(benzyloxy)-9H-xanthen-9-one (3.11) 
A solution of 9-(trifluoromethyl)-9H-xanthene-3,6,9-triol (300mg, 1.0mmol, 1eq.) in 
dimethylsulfoxide (7mL) and potassium hydroxide (282mg, 5mmol, 5eq.) was stirred under 
nitrogen at room temperature in a 25mL round bottom flask and monitored by TLC (10% methanol 
in dichloromethane). No starting material was seen on the plate after stirring for 85 minutes. 
Benzylbromide (430mg, 2.5mmol, 2.5eq.) was added and continued monitoring on TLC. Reaction 
went to completion after 10 minutes. The reaction mixture was diluted into 100ml of 1M 
hydrochloric acid solution. Product immediately precipitated which was stirred for 5 mins and 
filtered using a Buchner funnel with vacuum and dried overnight under pressure to afford 373mg 
of the desired compound corresponding to a yield of 91%. 1H NMR (300MHz, CDCl3,) δ 8.25 (d, 
J= 8.7, 2H), 7.43 (m, 10H), 7.01 (d, J= 9.0, 2H), 6.94 (s, 2H), 5.19 (s, 4H); MS (ES) Calc. for 
C27H20O4 [M+1]
+ 409.45; found 409.60 
 
 
3,6-bis(benzyloxy)-2,7-dihexyl-9H-xanthen-9-one (3.12) 
A solution of 2,7-dihexyl-3,6-dihydroxy-9H-xanthen-9-one SO-1-80b (70mg, 0.17mmol, 1eq.) in 
dimethylsulfoxide (7mL), benzylbromide (76mg, 0.42mmol, 2.5eq.) and cesium carbonate 
(172mg, 0.53mmol, 3eq.) was stirred under nitrogen at room temperature in a 25mL round bottom 
47 
 
flask and monitored by TLC (10% methanol in dichloromethane). No starting material was seen 
on the plate after stirring for 2 days. The reaction mixture was diluted into 100ml of 1M 
hydrochloric acid solution. Product immediately precipitated which was stirred for 5 mins and 
filtered using a Buchner funnel with vacuum and dried overnight under pressure to afford 94mg 
of the desired compound corresponding to a yield of 92%. 1H NMR (300MHz, CDCl3,) δ 8.08 (s, 
2H), 7.45 (m, 10H), 6.85 (s, 2H), 5.19 (s, 4H), 2.74 (m, 4H), 1.66 (m, 8H), 1.29 (m, 6H), 0.87 (m, 
8H); MS (ES) Calc. for C39H44O4 [M+H]
+ 577.76; found 577.40. 
 
 
3,6-bis(benzyloxy)-2,7-difluoro-9H-xanthen-9-one (3.13) 
A solution of 9-(trifluoromethyl)-2, 7-difluoro-9H-xanthene-3,6,9-triol from SO-1-57b2 (72mg, 
1.0mmol, 1eq.) in DMSO (2mL) and potassium hydroxide (60mg, 1mmol, 5eq.) was stirred under 
nitrogen at room temperature in a 25mL round bottom flask and monitored by TLC (10% methanol 
in dichloromethane). No starting material was seen on the plate after stirring for 22 hours. 
Benzylbromide (93mg, 0.54mmol, 2.5eq.) was added and continued monitoring on TLC. Reaction 
went to completion after 1 hour. The reaction mixture was diluted into 20ml of 1M hydrochloric 
acid solution. Product immediately precipitated which was stirred for 5 mins and filtered using a 
Buchner funnel under vacuum and dried overnight under pressure to afford 86mg of the desired 
compound corresponding to a yield of 91%. 1H NMR (300MHz, CDCl3,) δ 7.51 (d, J= 10.8, 2H), 
7.43 (m, 10H), 6.97 (d, J= 6.6, 2H), 5.26 (s, 4H); MS (ES) Calc. for C27H18F2O4 [M+H]
+ 445.43; 
found 445.35. 
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3,6-bis(allyloxy)-2,7-difluoro-9H-xanthen-9-one (3.14) 
A solution of 2,7-difluoro-3,6-dihydroxy-9H-xanthen-9-one (40mg, 0.15mmol, 1eq.) in 
dimethylsulfoxide (2mL) and allyl bromide (55mg, 0.45mmol, 3eq.) and caesium carbonate 
(149mg, 0.45mmol, 3eq.) was stirred under nitrogen at room temperature overnight. TLC (10% 
methanol in dichloromethane) the following morning showed all starting material has been used 
up. The reaction mixture was diluted into 20ml of 1M hydrochloric acid solution. Product 
immediately precipitated which was stirred for 5 mins and filtered using a Buchner funnel and 
dried overnight under pressure to afford 40mg of the desired compound corresponding to a yield 
of 75%. 1H NMR (300MHz, CDCl3,) δ 7.94  
(d, J= 10.8, 2H), 6.94 (d, J=6.6, 2H), 6.10 (m, 2H), 5.52 (d, J=17.1, 2H), 5.41 (d, J=10.5, 12H), 
4.73 (d, J=5.1, 4H); MS (ES) Calc. for C19H14F2O4 [M+1]
+ 345.09; found 345.25 
 
 
3,6-bis(allyloxy)-9H-xanthen-9-one (3.15) 
A solution of 3,6-dihydroxy-9H-xanthen-9-one (200mg, 0.87mmol, 1eq.) in DMF (6mL) and allyl 
bromide (212mg, 1.72mmol, 2eq.) and cesium carbonate (856mg, 2.61mmol, 3eq.) was stirred 
under nitrogen at room temperature overnight. TLC (10% methanol in dichloromethane) the 
following morning showed all starting material has been used up. The reaction mixture was diluted 
into 10ml of 1M hydrochloric acid solution. Product extracted with ethyl acetate (3x) and the 
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organic layer was washed with brine and passed through sodium sulfate and concentrated using 
the rotary evaporator and dried overnight under pressure to afford 254mg of the crude compound 
corresponding to a yield of 94%. 1H NMR (300MHz, CDCl3,) δ 8.25 (d, J= 8.7, 2H), 6.96 (d, J=9.0, 
2H), 6.87 (s, 2H), 6.10 (3, 2H), 5.50 (d, J=17.4, 2H), 5.38 (d, J=10.8, 2H), 4.67 (d, J= 4.80 ,4H; 
MS (ES) Calc. for C19H16O4 [M+1]
+ 309.33; found 309.25 
 
 
3,6-bis(benzyloxy)-9-(trifluoromethyl)-9H-xanthen-9-ol (3.16) 
 
To a  solution of 9-(trifluoromethyl)-9H-xanthene-3,6,9-triol (106mg, 0.22mmol, 1eq.) in DMSO 
(2mL) was added potassium hydroxide (62mg, 1.1mmol, 5eq.) and stirred at room temperature 
and monitored by TLC (5% methanol in DCM). After 7 hours of stirring TLC showed that all the 
starting material had been used up. The reaction mixture was diluted into 20ml of 1M HCl 
solution. Product immediately precipitated which was stirred for 5 mins and filtered using a 
Buchner funnel and dried overnight under pressure to afford 80mg of the desired compound 
corresponding to a yield of 96%. 1H NMR (300MHz, CDCl3,) δ 7.94 (d, J= 10.8, 2H), 6.94 (d, 
J=6.6, 2H), 6.10 (m, 2H), 5.52 (d, J=17.1, 2H), 5.41 (d, J=10.5, 12H), 4.73 (d, J=5.1, 4H); MS 
(ES) Calc. for C19H14F2O4 [M+1]
+ 345.09; found 345.25. Mp = 176-178oC 
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4. CONCLUSION 
In conclusion, we present a simple and efficient route to xanthones, and introduce a new class of 
fluorescent xanthine with potentially low photo bleaching properties. We used our procedure to 
synthesize in very high yield various derivatives of 3,6-dihydroxyxanthones. 2,7-difluoro,3,6-
dihydroxyxanthone is particularly interesting because we used a relatively cheaper starting 
material to synthesize 2,7-difluoro,3,6-dihydroxyxanthone in 2 steps with a 73% overall yield 
compared to earlier reported procedures: 8 steps process with an overall yield of 26% using a more 
expensive starting material and a 6 steps sequence with an overall yield of 32% again starting with 
a relatively more expensive starting material.  
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                     6.   APPENDIX: NMR AND MS DATA SHEET 
1H-NMR 4,5-dimethyl-9-(trifluoromethyl)-9H-xanthene-3,6,9-triol (3.02)
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MS 4,5-dimethyl-9-(trifluoromethyl)-9H-xanthene-3,6,9-triol (3.02) 
 
 
 
57 
 
 2,7-dichloro-9-(trifluoromethyl)-9H-xanthene-3,6,9-triol (3.04) 
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1H-NMR 2,7-dichloro-9-(trifluoromethyl)-9H-xanthene-3,6,9-triol (3.04) 
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F-NMR 2,7-difluoro-9-(trifluoromethyl)-9H-xanthene-3,6,9-triol (3.05)
 
60 
 
 
1H-NMR 2,7-difluoro-9-(trifluoromethyl)-9H-xanthene-3,6,9-triol (3.05) 
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MS 2,7-difluoro-9-(trifluoromethyl)-9H-xanthene-3,6,9-triol (3.05) 
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1H-NMR 2,7-dihexyl-9-(trifluoromethyl)-9H-xanthene-3,6,9-triol (3.03) 
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MS 2,7-dihexyl-9-(trifluoromethyl)-9H-xanthene-3,6,9-triol (3.03) 
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1H-NMR 3,6-dihydroxy-9H-xanthen-9-one (3.06) 
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MS 3,6-dihydroxy-9H-xanthen-9-one (3.06)
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1NMR-2,7-difluoro-3,6-dihydroxy-9H-xanthen-9-one (3.07) 
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MS-2,7-difluoro-3,6-dihydroxy-9H-xanthen-9-one (3.07) 
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1H-NMR 2,7-dichloro-3,6-dihydroxy-9H-xanthen-9-one (3.08) 
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MS 2,7-dichloro-3,6-dihydroxy-9H-xanthen-9-one (3.08) 
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1H-NMR 3,6-dihydroxy-4,5-dimethyl-9H-xanthen-9-one (3.09) 
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MS 3,6-dihydroxy-4,5-dimethyl-9H-xanthen-9-one (3.09) 
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1H-NMR 2,7-dihexyl-3,6-dihydroxy-9H-xanthen-9-one (3.10) 
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MS 2,7-dihexyl-3,6-dihydroxy-9H-xanthen-9-one (3.10) 
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1H-NMR 3,6-bis(benzyloxy)-9H-xanthen-9-one (3.11) 
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MS 3,6-bis(benzyloxy)-9H-xanthen-9-one (3.11) 
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1H-NMR 3,6-bis(benzyloxy)-2,7-dihexyl-9H-xanthen-9-one (3.12) 
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MS 3,6-bis(benzyloxy)-2,7-dihexyl-9H-xanthen-9-one (3.12) 
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1H-NMR 3,6-bis(benzyloxy)-2,7-difluoro-9H-xanthen-9-one (3.13) 
 
 
79 
 
MS 3,6-bis(benzyloxy)-2,7-difluoro-9H-xanthen-9-one (3.13) 
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1H-NMR 3,6-bis(allyloxy)-2,7-difluoro-9H-xanthen-9-one (3.14) 
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MS 3,6-bis(allyloxy)-2,7-difluoro-9H-xanthen-9-one (3.14) 
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1H-NMR 3,6-bis(allyloxy)-9H-xanthen-9-one (3.15) 
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MS 3,6-bis(allyloxy)-9H-xanthen-9-one (3.15) 
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1H-NMR 3,6-bis(benzyloxy)-9-(trifluoromethyl)-9H-xanthen-9-ol (3.16) 
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